About this trial
The aim of this project is to start a biological and clinical collection of patients presenting autoimmune, dysimmune or auto-inflammatory dermatological diseases. This collection will provide appropriate biological samples to identify new biomarkers and to be accessible to the medical, scientific and industrial communities for the identification of new therapeutic strategies.
Eligibility criteria
Qualifiers
Patients with autoimmune bullous dermatoses (pemphigus, pemphigoid and others),
Patients with systemic autoimmune diseases associated with skin damage (lupus, scleroderma, dermatomyositis for example),
Patients with cutaneous lupus
Patients with dysimmune skin diseases (psoriasis, eczema)
Disqualifiers
Patients under protective supervision (guardianship, curators)
Patients under 6 years old
Pregnant or breastfeeding woman
Trial design
Treatments tested in this trial
- Blood sampling
- Remainders of samples taken as part of the treatment